This conditional deletion of RIPK3 aids in understanding how cell-specific RIPK3 inhibition affects atherosclerosis and gives insight into the consequences of targeting components of the necroptosis pathway in a disease context. The gene discussed is RIPK3; the disease is atherosclerosis.